Eurobio Scientific reported €84.5 million in first-half 2026 revenue, up 4.5% year over year, with net income nearly doubling to €4.7 million. The company completed acquisition of CareDx's Lab Solutions business, strengthening its transplantation diagnostics portfolio with the AlloSeq product

Diagnostics

Categories